U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    GLS glutaminase [ Homo sapiens (human) ]

    Gene ID: 2744, updated on 10-Oct-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis.

    Pyruvate metabolism dictates fibroblast sensitivity to GLS1 inhibition during fibrogenesis.
    Contento G, Wilson JA, Selvarajah B, Platé M, Guillotin D, Morales V, Trevisani M, Pitozzi V, Bianchi K, Chambers RC., Free PMC Article

    10/2/2024
    CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.

    CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.
    Liu J, Zhang X, Yang M, Zhang X., Free PMC Article

    05/2/2024
    Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1.

    Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1.
    Zhu G, Guan F, Li S, Zhang Q, Zhang X, Qin Y, Sun Z, Peng S, Cheng J, Li Y, Ren R, Fan T, Liu H.

    04/25/2024
    Glutaminase (GLS1) gene expression in primary breast cancer.

    Glutaminase (GLS1) gene expression in primary breast cancer.
    Vidula N, Yau C, Rugo HS.

    11/13/2023
    SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation.

    SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation.
    Xue X, Zeng X, Wu X, Mu K, Dai Y, Wei Z.

    09/19/2023
    LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.

    LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.
    Chen Z, Wang Q, Huang L, Xu G, Hu J.

    08/4/2023
    Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han Population.

    Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han Population.
    Wang Y, Chen M, Yi F, Xu J, Liu C, Zhang Z, Wang P, Jin T, Chen M.

    06/2/2023
    Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma.

    Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma.
    Raninga PV, He Y, Datta KK, Lu X, Maheshwari UR, Venkat P, Mayoh C, Gowda H, Kalimutho M, Hooper JD, Khanna KK., Free PMC Article

    03/7/2023
    Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis.

    Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis.
    Chattopadhyaya S, Nagalingam RS, Ledingham DA, Moffatt TL, Al-Hattab DS, Narhan P, Stecy MT, O'Hara KA, Czubryt MP., Free PMC Article

    05/28/2022
    Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure.

    Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure.
    Schwuchow-Thonke S, Göbel S, Emrich T, Schmitt VH, Fueting F, Klank C, Escher F, Schultheiss HP, Münzel T, Keller K, Wenzel P., Free PMC Article

    11/22/2021
    Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR3303p/GLS axis.

    Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis.
    Qian C, Chen S, Li S, Wang Y, Yao J., Free PMC Article

    10/30/2021
    A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.

    A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
    Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, Tang DG, Dong X, He Y, George D, Hu H, Huang J., Free PMC Article

    10/23/2021
    GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway.

    GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway.
    Liu HY, Zhang HS, Liu MY, Li HM, Wang XY, Wang M.

    09/11/2021
    Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.

    Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.
    de Los Santos-Jiménez J, Campos-Sandoval JA, Márquez-Torres C, Urbano-Polo N, Brøndegaard D, Martín-Rufián M, Lobo C, Peñalver A, Gómez-García MC, Martín-Campos J, Cardona C, Castilla L, da Costa Souza F, Cheng T, Segura JA, Alonso FJ, Curi R, Colquhoun A, DeBerardinis RJ, Márquez J, Matés JM., Free PMC Article

    09/4/2021
    A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues.

    A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues.
    Chen Y, Zhao Y, Bajor DL, Wang Z, Selfridge JE., Free PMC Article

    07/10/2021
    Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

    Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.
    Simon J, Nuñez-García M, Fernández-Tussy P, Barbier-Torres L, Fernández-Ramos D, Gómez-Santos B, Buqué X, Lopitz-Otsoa F, Goikoetxea-Usandizaga N, Serrano-Macia M, Rodriguez-Agudo R, Bizkarguenaga M, Zubiete-Franco I, Gutiérrez-de Juan V, Cabrera D, Alonso C, Iruzubieta P, Romero-Gomez M, van Liempd S, Castro A, Nogueiras R, Varela-Rey M, Falcón-Pérez JM, Villa E, Crespo J, Lu SC, Mato JM, Aspichueta P, Delgado TC, Martínez-Chantar ML., Free PMC Article

    07/3/2021
    The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers.

    The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers.
    Winarno GNA, Hidayat YM, Soetopo S, Krisnadi SR, Tobing MDL, Rauf S., Free PMC Article

    07/3/2021
    SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.

    SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.
    Tong Y, Guo D, Lin SH, Liang J, Yang D, Ma C, Shao F, Li M, Yu Q, Jiang Y, Li L, Fang J, Yu R, Lu Z.

    06/26/2021
    SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3beta/CyclinD1 pathway.

    SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway.
    Cui Y, Bai Y, Yang J, Yao Y, Zhang C, Liu C, Shi J, Li Q, Zhang J, Lu X, Zhang Y.

    06/26/2021
    Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein-Barr Virus Infected Cells.

    Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein-Barr Virus Infected Cells.
    Krishna G, Soman Pillai V, Valiya Veettil M., Free PMC Article

    02/27/2021
    GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.

    GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.
    Xia X, Cao G, Sun G, Zhu L, Tian Y, Song Y, Guo C, Wang X, Zhong J, Zhou W, Li P, Zhang H, Hao J, Li Z, Deng L, Yin Z, Gao Y., Free PMC Article

    02/27/2021
    Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders.

    Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders.
    Johmura Y, Yamanaka T, Omori S, Wang TW, Sugiura Y, Matsumoto M, Suzuki N, Kumamoto S, Yamaguchi K, Hatakeyama S, Takami T, Yamaguchi R, Shimizu E, Ikeda K, Okahashi N, Mikawa R, Suematsu M, Arita M, Sugimoto M, Nakayama KI, Furukawa Y, Imoto S, Nakanishi M.

    02/13/2021
    Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.

    Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
    Shen YA, Hong J, Asaka R, Asaka S, Hsu FC, Suryo Rahmanto Y, Jung JG, Chen YW, Yen TT, Tomaszewski A, Zhang C, Attarwala N, DeMarzo AM, Davidson B, Chuang CM, Chen X, Gaillard S, Le A, Shih IM, Wang TL., Free PMC Article

    02/13/2021
    NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.

    NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.
    Gao CC, Xu QQ, Xiao FJ, Wang H, Wu CT, Wang LS.

    12/5/2020
    Targeting cellular metabolism to reduce head and neck cancer growth.

    Targeting cellular metabolism to reduce head and neck cancer growth.
    Yang J, Guo Y, Seo W, Zhang R, Lu C, Wang Y, Luo L, Paul B, Yan W, Saxena D, Li X., Free PMC Article

    10/3/2020
    firstprevious page of 5 nextlast